Self
Should Australia Subsidize Antiobesity Drugs?
The use of GLP-1 agonists such as Wegovy, Ozempic, and Mounjaro is rapidly rising in Australia, but their high costs are fueling debate over whether
The use of GLP-1 agonists such as Wegovy, Ozempic, and Mounjaro is rapidly rising in Australia, but their high costs are fueling debate over whether